116
|
385
|
1ovaA |
Crystal structure of uncleaved ovalbumin at 1.95 angstroms resolution |
113
|
374
|
1oc0A |
Plasminogen activator inhibitor-1 complex with somatomedin b domain of vitronectin |
118
|
426
|
1nq9I |
Crystal structure of antithrombin in the pentasaccharide-bound intermediate state |
89
|
320
|
1mtpA |
The x-ray crystal structure of a serpin from a thermophilic prokaryote |
58
|
245
|
1m93B |
1.65 a structure of cleaved viral serpin crma |
94
|
329
|
1lq8A |
Crystal structure of cleaved protein c inhibitor |
113
|
427
|
1lk6I |
Structure of dimeric antithrombin complexed with a p14-p9 reactive loop peptide and an exogenous tripeptide |
116
|
379
|
1lj5A |
1.8a resolution structure of latent plasminogen activator inhibitor-1(pai-1) |
35
|
375
|
1kctA |
Alpha1-antitrypsin |
102
|
385
|
1jtiA |
Loop-inserted structure of p1-p1' cleaved ovalbumin mutant r339t |
88
|
376
|
1k9oI |
Crystal structure of michaelis serpin-trypsin complex |
104
|
381
|
1jrrA |
Human plasminogen activator inhibitor-2.[loop (66-98) deletionmutant] complexed with peptide mimicking the reactive center loop |
113
|
427
|
1jvqI |
Crystal structure at 2.6a of the ternary complex between antithrombin, a p14-p8 reactive loop peptide, and an exogenous tetrapeptide |
98
|
376
|
1hp7A |
A 2.1 angstrom structure of an uncleaved alpha-1-antitrypsin shows variability of the reactive center and other loops |
102
|
344
|
1hleA |
Crystal structure of cleaved equine leucocyte elastase inhibitor determined at 1.95 angstroms resolution |
125
|
420
|
1jmjA |
Crystal structure of native heparin cofactor ii |
128
|
427
|
1jmoA |
Crystal structure of the heparin cofactor ii-s195a thrombin complex |
48
|
261
|
1jjoC |
Crystal structure of mouse neuroserpin (cleaved form) |
79
|
305
|
1f0cA |
Structure of the viral serpin crma |
95
|
335
|
1ezxA |
Crystal structure of a serpin:protease complex |
110
|
428
|
1dzhI |
P14-fluorescein-n135q-s380c-antithrombin-iii |
111
|
427
|
1e04I |
Plasma beta antithrombin-iii |
115
|
379
|
1dvnA |
Latent form of plasminogen activator inhibitor-1 (pai-1) |
104
|
428
|
1dzgI |
N135q-s380c-antithrombin-iii |
109
|
424
|
1dzgL |
N135q-s380c-antithrombin-iii |
113
|
376
|
1dvmA |
Active form of human pai-1 |
119
|
426
|
1e03I |
Plasma alpha antithrombin-iii and pentasaccharide |
106
|
424
|
1dzhL |
P14-fluorescein-n135q-s380c-antithrombin-iii |
110
|
429
|
1e05I |
Plasma alpha antithrombin-iii |
114
|
377
|
1db2A |
Crystal structure of native plasminogen activator inhibitor-1 |
87
|
334
|
1d5sA |
Crystal structure of cleaved antitrypsin polymer |
70
|
300
|
1c8oA |
2.9 a structure of cleaved viral serpin crma |
104
|
379
|
1c5gA |
Plasminogen activator inhibitor-1 |
96
|
371
|
1iz2A |
Interactions causing the kinetic trap in serpin protein folding |
114
|
381
|
1by7A |
Human plasminogen activator inhibitor-2. loop (66-98) deletion mutant |
95
|
425
|
1br8I |
Implications for function and therapy of a 2.9a structure of binary-complexed antithrombin |
103
|
336
|
1as4A |
Cleaved antichymotrypsin a349r |
115
|
425
|
1athA |
The intact and cleaved human antithrombin iii complex as a model for serpin-proteinase interactions |
53
|
374
|
1atuA |
Uncleaved alpha-1-antitrypsin |
121
|
429
|
1attA |
Crystal structure of cleaved bovine antithrombin iii at 3.2 angstroms resolution |
101
|
373
|
1b3kA |
Plasminogen activator inhibitor-1 |
125
|
430
|
1azxI |
Antithrombin/pentasaccharide complex |
98
|
420
|
1antI |
Biological implications of a 3 angstroms structure of dimeric antithrombin |
101
|
383
|
1imvA |
2.85 a crystal structure of pedf |
107
|
378
|
1a7cA |
Human plasminogen activator inhibitor type-1 in complex with a pentapeptide |